Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C17H35N5O6 |
| Molecular Weight | 405.4897 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 10 / 10 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CO[C@H]1[C@@H](O)[C@H](N)[C@@H](O[C@H]2O[C@@H](CC[C@H]2N)[C@H](C)N)[C@H](O)[C@@H]1N(C)C(=O)CN
InChI
InChIKey=BIDUPMYXGFNAEJ-APGVDKLISA-N
InChI=1S/C17H35N5O6/c1-7(19)9-5-4-8(20)17(27-9)28-15-11(21)13(24)16(26-3)12(14(15)25)22(2)10(23)6-18/h7-9,11-17,24-25H,4-6,18-21H2,1-3H3/t7-,8+,9-,11-,12-,13-,14+,15+,16+,17+/m0/s1
| Molecular Formula | C17H35N5O6 |
| Molecular Weight | 405.4897 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 10 / 10 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionCurator's Comment: description was created based on several sources, including:
http://www.et97.com/view/526697.htm
Curator's Comment: description was created based on several sources, including:
http://www.et97.com/view/526697.htm
Astromicin is an aminoglycoside antibiotic produced by Micromonospora spp. It is effective against major gram-negative bacterias such as Proteus, Serratia, Citrobacter, Enterobacter spp., Klebsiella, Escherichia coli and Staphylococcus aureus. Astromicin sulfate has been given by intramuscular injection or intravenous infusion. Side effects are: rash, urticaria, itch, erythema, fever, nausea, vomiting, and diarrhea. Combination with strong diuretics can cause nephrotoxicity and ototoxicity.
Originator
Sources: https://www.google.com/patents/US3976768
Curator's Comment: Fortimicin B:https://www.google.ch/patents/US3931400
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2363135 Sources: http://www.ncbi.nlm.nih.gov/pubmed/6395800 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Curative | Fortimicin Approved UseIt is used for treatment of bronchitis |
|||
| Curative | Fortimicin Approved UseIt is used for treatment of pyelonephritis |
|||
| Curative | Fortimicin Approved UseIt is used for treatment of cystitis. |
|||
| Curative | Fortimicin Approved UseIt is used for the treatment of pneumonia. |
|||
| Curative | Fortimicin Approved UseIt is used for treatment of peritonitis. |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Photorhabdus luminescens genes induced upon insect infection. | 2008-05-19 |
|
| [Functional characterization of a multiple-antibiotic resistant plasmid from clinical isolates of methicillin-resistant Staphylococcus aureus]. | 2001-05 |
|
| Neuromuscular blocking effects of the aminoglycoside antibiotics arbekacin, astromicin, isepamicin and netilmicin on the diaphragm and limb muscles in the rabbit. | 2001 |
Sample Use Guides
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/6792980
MIC50 against Pseudomonas aeruginosa is 10 ug/ml
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:04:54 GMT 2025
by
admin
on
Mon Mar 31 18:04:54 GMT 2025
|
| Record UNII |
7JHD84H15J
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C2363
Created by
admin on Mon Mar 31 18:04:54 GMT 2025 , Edited by admin on Mon Mar 31 18:04:54 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C023384
Created by
admin on Mon Mar 31 18:04:54 GMT 2025 , Edited by admin on Mon Mar 31 18:04:54 GMT 2025
|
PRIMARY | |||
|
C76146
Created by
admin on Mon Mar 31 18:04:54 GMT 2025 , Edited by admin on Mon Mar 31 18:04:54 GMT 2025
|
PRIMARY | |||
|
55779-06-1
Created by
admin on Mon Mar 31 18:04:54 GMT 2025 , Edited by admin on Mon Mar 31 18:04:54 GMT 2025
|
PRIMARY | |||
|
37923
Created by
admin on Mon Mar 31 18:04:54 GMT 2025 , Edited by admin on Mon Mar 31 18:04:54 GMT 2025
|
PRIMARY | |||
|
5284517
Created by
admin on Mon Mar 31 18:04:54 GMT 2025 , Edited by admin on Mon Mar 31 18:04:54 GMT 2025
|
PRIMARY | |||
|
DTXSID2022624
Created by
admin on Mon Mar 31 18:04:54 GMT 2025 , Edited by admin on Mon Mar 31 18:04:54 GMT 2025
|
PRIMARY | |||
|
CHEMBL3084803
Created by
admin on Mon Mar 31 18:04:54 GMT 2025 , Edited by admin on Mon Mar 31 18:04:54 GMT 2025
|
PRIMARY | |||
|
100000086610
Created by
admin on Mon Mar 31 18:04:54 GMT 2025 , Edited by admin on Mon Mar 31 18:04:54 GMT 2025
|
PRIMARY | |||
|
7JHD84H15J
Created by
admin on Mon Mar 31 18:04:54 GMT 2025 , Edited by admin on Mon Mar 31 18:04:54 GMT 2025
|
PRIMARY | |||
|
m5545
Created by
admin on Mon Mar 31 18:04:54 GMT 2025 , Edited by admin on Mon Mar 31 18:04:54 GMT 2025
|
PRIMARY | Merck Index | ||
|
SUB05587MIG
Created by
admin on Mon Mar 31 18:04:54 GMT 2025 , Edited by admin on Mon Mar 31 18:04:54 GMT 2025
|
PRIMARY | |||
|
ASTROMICIN
Created by
admin on Mon Mar 31 18:04:54 GMT 2025 , Edited by admin on Mon Mar 31 18:04:54 GMT 2025
|
PRIMARY | |||
|
250
Created by
admin on Mon Mar 31 18:04:54 GMT 2025 , Edited by admin on Mon Mar 31 18:04:54 GMT 2025
|
PRIMARY | |||
|
4904
Created by
admin on Mon Mar 31 18:04:54 GMT 2025 , Edited by admin on Mon Mar 31 18:04:54 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |